New York, NY (PRWEB) September 18, 2012
For many Americans, pharmacies have remained a vital part of maintaining one’s health throughout modern history. However, a recent article from Forbes suggests that those within the pharmaceutical industry, such as pharmacists and drug manufacturers, must adapt to the changing landscape of American health. In particular, the article focuses on a growing need to address continued management of long-term chronic diseases, rather than taking the one-medication-fits-all approach that has proven to be effective in the treatment of infectious diseases. As a professional who has worked in several different capacities within the industry, Mary Pat Higley comments on this growing need and offers her thoughts on how professionals, as a whole, can address this widespread problem.
The article explains, “With infections, medicines have been incredibly effective, because symptoms are predictable and consistent across demographics. But in the world of complex or lifestyle diseases that have moved to the top of our healthcare priorities, we must consider issues such as our genetic profile, upbringing, environment, fitness, stress levels, sleep and diet.” These observations have led to three suggestions formed by the article’s author on how to “transform innovation in pharma.” Mary Pat Higley comments, “Pharmaceutical companies have traditionally developed medications that treat disease, such as infection, which have very little connection to patient behavior, lives or lifestyle.”
The article advocates that pharmaceutical technology be used to formulate more personalized treatments; that medical professionals and drug manufacturers “treat people, rather than disease states”; and that patients become empowered to understand and embrace long-term management of their health problems.
As a clinical pharmacist and clinical researcher, Mary Pat Higley takes a similar approach, noting the need for those within the medical community to improve patient care. In response to the Forbes article, Mary Pat Higley concludes, “Since environmental factors, such as fast food, high sugar intake and sedentary lifestyle, contribute to many diseases and are occurring at younger ages in our population, new drug development that combines lifestyle modifications is necessary. For instance, HTN medications and exercise, or lipid-lowering drugs paired with weight loss programs, would help change the mentality of just taking a pill to fix the problems.”
Mary Pat Higley is a dedicated professional who has built a successful career within the pharmaceutical industry by combining scientific knowledge with business experience. Having a career that spans over three decades, Mary Pat Higley has expanded her professional acumen that has included work in clinical pharmacy, clinical research, project marketing, sales and marketing roles. As a member of the Associates of Clinical Research Professionals and the American Society of Hospital Pharmacy, Mary Pat Higley is committed to improving patient care and contributing to the progression of national health.